GlycanAge
Newcastle Upon Tyne
About GlycanAge
GlycanAge stands at the forefront of the health-tech and longevity sectors, boasting a technology forged from over three decades of rigorous research and analysis of 200,000 testing samples. Utilizing the largest proprietary dataset of human glycome, GlycanAge is pioneering advanced blood biomarkers for the prediction of age-related diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $14.0M
- Last round: Series Unknown (Dec 2025)
- Website: glycanage.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/glycanage-26772 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.